Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lonchampt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1979
The effect of high glucose concentration on the proliferation and the synthesis of lipids in endothelial cells in cultureJ Duhault, J Bure, M O Lonchampt, et al.
Arzneimittel-Forschung|December 1, 1987
Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activityJ Duhault, M Boulanger, M Lonchampt, et al.
European Journal of Pharmacology|December 29, 1995
In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonistP Robineau, M Lonchampt, N Kucharczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammationM Félétou, M Lonchampt, P Robineau, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivoM Félétou, P Robineau, M Lonchampt, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 19, 2001
Regulation of murine airway responsiveness by endothelial nitric oxide synthaseM Feletou, M Lonchampt, F Coge, et al.
Journal of Nutrigenetics and Nutrigenomics|July 16, 2011
Aging and obesity induce distinct gene expression adaptation in the liver of C57BL/6J miceF Capel, M H Delmotte, M Brun, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1979
The effect of high glucose concentration on the proliferation and the synthesis of lipids in endothelial cells in cultureJ Duhault, J Bure, M O Lonchampt, et al.
Arzneimittel-Forschung|December 1, 1987
Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activityJ Duhault, M Boulanger, M Lonchampt, et al.
European Journal of Pharmacology|December 29, 1995
In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonistP Robineau, M Lonchampt, N Kucharczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammationM Félétou, M Lonchampt, P Robineau, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivoM Félétou, P Robineau, M Lonchampt, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 19, 2001
Regulation of murine airway responsiveness by endothelial nitric oxide synthaseM Feletou, M Lonchampt, F Coge, et al.
Journal of Nutrigenetics and Nutrigenomics|July 16, 2011
Aging and obesity induce distinct gene expression adaptation in the liver of C57BL/6J miceF Capel, M H Delmotte, M Brun, et al.
Pageof 2